Next Article in Journal
RETRACTED: Khan et al. Norfloxacin Loaded Lipid Polymer Hybrid Nanoparticles for Oral Administration: Fabrication, Characterization, In Silico Modelling and Toxicity Evaluation. Pharmaceutics 2021, 13, 1632
Previous Article in Journal
Transcriptome-Guided Drug Repurposing Identifies Homoharringtonine (HHT) as a Candidate for Radiation-Induced Pulmonary Fibrosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 17
Issue 12
10.3390/pharmaceutics17121625
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2025, 17(1), 128.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Ortiz-Islas et al. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128

by
Emma Ortiz-Islas
1,
Pedro Montes
2,
Citlali Ekaterina Rodríguez-Pérez
1,
Elizabeth Ruiz-Sánchez
3,
Talía Sánchez-Barbosa
4,5,
Diego Pichardo-Rojas
6,
Cecilia Zavala-Tecuapetla
4,
Karla Carvajal-Aguilera
7 and
Victoria Campos-Peña
4,*
1
Laboratorio de Neurofarmacologia Molecular y Nanotecnologia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico
2
Laboratorio de Neuroinmunoendocrinología, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico
3
Laboratorio de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico
4
Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico
5
Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City 07360, Mexico
6
Programa Prioritario de Epilepsia, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico
7
Laboratorio de Nutrición Experimental, Instituto Nacional de Pediatría, Mexico City 04530, Mexico
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(12), 1625; https://doi.org/10.3390/pharmaceutics17121625
Submission received: 30 October 2025 / Accepted: 25 November 2025 / Published: 18 December 2025
(This article belongs to the Section Nanomedicine and Nanotechnology)
Versions Notes
References
The original reference 253 has been retracted and its contents are no longer of reference value. The authors would like to make the following corrections for their published paper [1]:
Deleting original reference 253:
253. Gao, C.; Chu, X.; Gong, W.; Zheng, J.; Xie, X.; Wang, Y.; Yang, M.; Li, Z.; Gao, C.; Yang, Y. Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease. J. Nanobiotechnol. 2020, 18, 71. https://doi.org/10.1186/s12951-020-00626-1.
With this correction, the order of some references has been adjusted accordingly. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Ortiz-Islas, E.; Montes, P.; Rodríguez-Pérez, C.E.; Ruiz-Sánchez, E.; Sánchez-Barbosa, T.; Pichardo-Rojas, D.; Zavala-Tecuapetla, C.; Carvajal-Aguilera, K.; Campos-Peña, V. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ortiz-Islas, E.; Montes, P.; Rodríguez-Pérez, C.E.; Ruiz-Sánchez, E.; Sánchez-Barbosa, T.; Pichardo-Rojas, D.; Zavala-Tecuapetla, C.; Carvajal-Aguilera, K.; Campos-Peña, V. Correction: Ortiz-Islas et al. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. Pharmaceutics 2025, 17, 1625. https://doi.org/10.3390/pharmaceutics17121625

AMA Style

Ortiz-Islas E, Montes P, Rodríguez-Pérez CE, Ruiz-Sánchez E, Sánchez-Barbosa T, Pichardo-Rojas D, Zavala-Tecuapetla C, Carvajal-Aguilera K, Campos-Peña V. Correction: Ortiz-Islas et al. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. Pharmaceutics. 2025; 17(12):1625. https://doi.org/10.3390/pharmaceutics17121625

Chicago/Turabian Style

Ortiz-Islas, Emma, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, Elizabeth Ruiz-Sánchez, Talía Sánchez-Barbosa, Diego Pichardo-Rojas, Cecilia Zavala-Tecuapetla, Karla Carvajal-Aguilera, and Victoria Campos-Peña. 2025. "Correction: Ortiz-Islas et al. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128" Pharmaceutics 17, no. 12: 1625. https://doi.org/10.3390/pharmaceutics17121625

APA Style

Ortiz-Islas, E., Montes, P., Rodríguez-Pérez, C. E., Ruiz-Sánchez, E., Sánchez-Barbosa, T., Pichardo-Rojas, D., Zavala-Tecuapetla, C., Carvajal-Aguilera, K., & Campos-Peña, V. (2025). Correction: Ortiz-Islas et al. Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. Pharmaceutics 2025, 17, 128. Pharmaceutics, 17(12), 1625. https://doi.org/10.3390/pharmaceutics17121625

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop